Aeolus Pharmaceuticals Inc. announced consolidated earnings results for the fourth quarter and full year ended September 30, 2016. For the fourth quarter, the company reported total revenues were $546,000 as compared to $934,000 in the fourth quarter of fiscal year 2015. Net loss was $1,024,000 or $0.00 per share as compared to $434,000 or $0.00 per share in the fourth quarter of fiscal year 2015. For the year, the company reported contract revenue of $2,076,000 compared to $3,111,000 a year ago. Loss from operations was $3,273,000 compared to $2,626,000 a year ago. Net loss was $3,558,000 or $0.04 per basic and diluted share compared to $2,628,000 or $0.02 per basic and diluted share a year ago. Diluted net loss attributable to common stockholders was $6,044,000 compared to $2,628 a year ago. Net cash used in operating activities was $3,109,000 compared to $2,443,000 a year ago.